DALLAS, Jan. 25, 2016 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today reported year-end 2015 results and provided its 2016 outlook and related key planning assumptions.
Executive Summary
Chairman and Chief Executive Officer Thomas J. Falk said, "Our fourth quarter results capped off another year of good financial performance for Kimberly-Clark. For the full year of 2015, we achieved 5 percent organic sales growth, highlighted by 10 percent growth in developing and emerging markets and a 5 percent volume increase in our North American consumer products business. We also improved adjusted operating profit margin by 120 basis points, including benefits from $365 million of FORCE cost savings. In addition, we grew adjusted earnings per share from continuing operations 5 percent, toward the high end of our original guidance for the year despite significantly more currency headwinds. Finally, we improved return on invested capital considerably and returned $2.1 billion to shareholders through dividends and share repurchases. I'm pleased with our execution in a challenging environment."
Falk added, "Looking to 2016, we will continue to focus on the fundamentals that create shareholder value and we expect to deliver good underlying financial performance. We will also continue to invest in our brands, our targeted growth initiatives and our capabilities. We plan to achieve healthy organic sales growth and cost savings, improve cash flow and allocate capital in shareholder-friendly ways. Despite another year of significantly unfavorable currencies, we also expect to further improve our margins and deliver 3 to 7 percent growth in adjusted earnings per share. We are very optimistic about our future and our ability to generate attractive returns to shareholders through successful execution of our Global Business Plan."
Fourth Quarter 2015 Operating Results
Sales of $4.5 billion in the fourth quarter of 2015 were down 6 percent compared to the year-ago period. Changes in foreign currency exchange rates reduced sales 11 percent as a result of the weakening of most currencies relative to the U.S. dollar. Organic sales rose 5 percent, as volumes increased 4 percent and net selling prices improved 1 percent.
Fourth quarter operating profit was $630 million in 2015 and $158 million in 2014. Adjusted operating profit was $779 million in the fourth quarter of 2015 compared to $769 million in the year-ago period. Adjusted results in 2015 exclude $108 million of charges for the Venezuelan deconsolidation, $27 million of 2014 Organization Restructuring costs, $8 million of charges for pension settlements and $6 million of charges for restructuring the company's business in Turkey. Adjusted results in 2014 exclude a $462 million charge for a balance sheet remeasurement in Venezuela, $133 million of 2014 Organization Restructuring costs, $20 million of restructuring costs for European strategic changes and $4 million of income related to an updated assessment regarding a regulatory dispute in the Middle East.
The year-over-year adjusted operating profit comparison benefited from organic sales growth, $85 million in cost savings from the company's FORCE (Focused On Reducing Costs Everywhere) program and $15 million of savings from the 2014 Organization Restructuring. Input costs decreased $50 million, including $45 million of lower costs for raw materials other than fiber and $5 million of lower energy costs. Other manufacturing-related costs also decreased versus the year-ago period. Translation effects due to changes in foreign currency exchange rates lowered operating profit by $85 million and transaction effects also negatively impacted the comparison. Total marketing, research and general expenses increased on a local currency basis, mostly due to higher administrative and selling costs. On an adjusted basis, other (income) and expense, net was expense of $23 million in 2015 and $7 million in 2014. Results in 2015 were driven by foreign currency transaction losses, including impacts of the devaluation of the Argentine peso in December 2015.
The fourth quarter adjusted effective tax rate, which excludes the effects of the previously mentioned items excluded from adjusted earnings per share, was 30.6 percent in 2015 and 30.5 percent in 2014. The adjusted effective tax rate in the fourth quarter of 2015 also excludes the impact of a $49 million tax charge, related to prior years, as a result of an updated assessment of uncertain tax positions. Kimberly-Clark's share of net income of equity companies in the fourth quarter was $37 million in 2015 and $33 million in 2014. At Kimberly-Clark de Mexico, results benefited from organic sales growth, lower input costs and cost savings, but were negatively impacted by a weaker Mexican peso. Fourth quarter net income attributable to noncontrolling interests was $11 million in 2015 and $20 million in 2014. The change was driven by the redemption of $0.5 billion of preferred securities in December 2014.
Cash Flow and Balance Sheet
Cash provided by operations in the fourth quarter of 2015 was $665 million versus $590 million in 2014. Full-year cash provided by operations was $2,306 million in 2015 and $2,845 million in 2014. The comparison was negatively impacted by higher pension contributions, increased working capital and the 2014 spin-off of the health care business, partially offset by lower tax payments. Full-year defined benefit pension plan contributions were $485 million in 2015 and $185 million in 2014.
Capital spending for the fourth quarter was $258 million in 2015 and $309 million in 2014. Full-year spending was $1,056 million in 2015 and $1,039 million in 2014. Fourth quarter 2015 share repurchases were 2.9 million shares at a cost of $350 million. Full-year 2015 share repurchases totaled 7.1 million shares at a cost of $800 million. Total debt was $7.8 billion at the end of 2015 and $7.0 billion at the end of 2014.
Fourth Quarter 2015 Business Segment Results
Personal Care Segment
Fourth quarter sales of $2.2 billion decreased 4 percent. Currency rates were unfavorable by 12 percent. Volumes increased 6 percent and net selling prices and product mix were each favorable by 1 percent. Fourth quarter operating profit of $473 million increased 15 percent. The comparison benefited from organic sales growth, cost savings and lower input and other manufacturing-related costs, partially offset by unfavorable currency effects and increased marketing, research and general spending on a local currency basis.
Sales in North America increased 4 percent. Volumes improved 5 percent, while currency was unfavorable by 1 percent. Volumes were up double-digits in adult care, with benefits from category growth and market share gains. Volumes on Huggies diapers rose mid-single digits compared to a 10 percent decline in the year-ago period and included benefits from innovation and increased promotion support. Child care and feminine care volumes were each up low-single digits, while Huggies baby wipes volumes were off double-digits compared to strong double-digit growth in the prior year.
Sales in developing and emerging markets decreased nearly 12 percent, including a negative impact from changes in currency rates of more than 23 percent. Volumes increased 6 percent and the combined impact of higher net selling prices and changes in product mix improved sales 6 percent. The volume growth included gains in China and most of Latin America, led by Brazil. The higher net selling prices were driven by increases in Eastern Europe and Latin America in response to weaker currency rates.
Sales in developed markets outside North America (Australia, South Korea and Western/Central Europe) decreased 9 percent, including a 12 point drag from unfavorable currency rates. Volumes rose 4 percent, driven by Australia, while the combined impact of changes in net selling prices and product mix reduced sales 1 percent.
Consumer Tissue Segment
Fourth quarter sales of $1.5 billion decreased 6 percent. Currency rates were unfavorable by 9 percent. Volumes increased 4 percent, while net selling prices were down 1 percent. Fourth quarter operating profit of $262 million decreased 6 percent. The comparison was impacted by unfavorable currencies, partially offset by cost savings and organic sales growth.
Sales in North America increased 4 percent. Volumes increased 8 percent, while net selling prices were off 2 percent and product mix was unfavorable by more than 1 percent. Volume growth was particularly strong on Cottonelle bathroom tissue and Viva paper towels and included benefits from market share gains and promotion activity.
Sales in developing and emerging markets decreased 23 percent, including a 26 point negative impact from currency rates. Net selling prices rose 4 percent.
Sales in developed markets outside North America fell 10 percent. Currency rates were unfavorable 10 percent. Volumes advanced 1 percent and product mix improved slightly, while net selling prices were off 2 percent.
K-C Professional (KCP) Segment
Fourth quarter sales of $0.8 billion decreased 9 percent. Changes in currency rates reduced sales 9 percent. Volumes were off 2 percent and product mix/other was slightly unfavorable, while net selling prices rose 2 percent. Fourth quarter operating profit of $157 million increased 4 percent. The comparison was impacted by higher net selling prices and cost savings, partially offset by unfavorable currency effects.
Sales in North America were down 1 percent. Currency was unfavorable 1 percent. Net selling prices increased 1 percent, while volumes were off 1 percent.
Sales in developing and emerging markets decreased 19 percent, including a 21 point drag from currency rates. Net selling prices rose 4 percent, driven by increases in Latin America in response to weaker currency rates, and product mix was favorable by 1 percent. Volumes declined 4 percent.
Sales in developed markets outside North America were down 15 percent. Changes in currency rates reduced sales more than 11 percent. Volumes decreased 3 percent compared to a strong year-ago result.
Full Year 2015 Results
Sales of $18.6 billion decreased 6 percent compared to the year-ago period, as changes in foreign currency exchange rates reduced sales more than 10 percent. Organic sales rose approximately 5 percent, as volumes increased 4 percent and product mix/other was favorable by 1 percent.
Operating profit was $1,613 million in 2015 versus $2,521 million in 2014. Adjusted operating profit of $3,210 million in 2015 increased 1 percent compared to $3,184 million in 2014. Adjusted operating profit comparisons benefited from organic sales growth, FORCE cost savings of $365 million, input cost deflation of $150 million and $65 million of savings from the 2014 Organization Restructuring. Translation effects due to changes in foreign currency exchange rates lowered operating profit by $360 million and transaction effects also negatively impacted the operating profit comparisons. Total marketing, research and general expenses increased on a local currency basis, driven by higher administrative costs. On an adjusted basis, other (income) and expense, net was expense of $62 million in 2015, driven by foreign currency transaction losses, and income of $3 million in 2014.
Diluted net income per share was $2.77 in 2015 and $4.04 in 2014. Adjusted earnings per share of $5.76 in 2015 increased 5 percent versus $5.51 of adjusted earnings per share from continuing operations in 2014. The increase included benefits from higher adjusted operating profit and a lower share count.
Venezuela Update
At the end of 2015, Kimberly-Clark deconsolidated the assets and liabilities of its Venezuelan business from the company's balance sheet and moved to the cost method of accounting for its operations in Venezuela. The change reflects the continued deterioration of conditions in the country, including a slowdown in the availability of foreign exchange, and resulted in an after tax charge of $102 million in the fourth quarter of 2015. Beginning in the first quarter of 2016, the company will no longer include the results of its Venezuelan business in its consolidated financial statements. Kimberly-Clark continues to manufacture and sell products in Venezuela when foreign exchange is received to pay for imports of raw materials and finished goods.
2014 Organization Restructuring
In October 2014, Kimberly-Clark initiated a restructuring program in order to improve organization efficiency and offset the impact of stranded overhead costs resulting from the spin-off of the company's health care business. The restructuring is intended to improve underlying profitability and increase flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth.
The restructuring is expected to be completed by the end of 2016, with total costs anticipated to be toward the middle of the previously communicated range of $130 to $160 million after tax ($190 to $230 million pre-tax). Cumulative pre-tax savings from the restructuring are expected to be $120 to $140 million by the end of 2017. Fourth quarter 2015 restructuring costs were $22 million after tax ($27 million pre-tax), bringing cumulative costs to $137 million after tax ($196 million pre-tax). Fourth quarter 2015 savings were $15 million, bringing cumulative savings to $70 million.
2016 Outlook and Key Planning Assumptions
The company's key planning and guidance assumptions for 2016 are as follows:
Non-GAAP Financial Measures
This press release and the accompanying tables include the following financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as non-GAAP financial measures:
These non-GAAP financial measures exclude the following items for the relevant time periods as indicated in the accompanying non-GAAP reconciliations to the comparable GAAP financial measures:
In addition, this press release includes information regarding organic sales, which exclude the impact of changes in foreign currency rates.
The company provides these non-GAAP financial measures as supplemental information to our GAAP financial measures. Management and the company's Board of Directors use adjusted earnings, adjusted earnings per share and adjusted gross and operating profit to (a) evaluate the company's historical and prospective financial performance and its performance relative to its competitors, (b) allocate resources and (c) measure the operational performance of the company's business units and their managers. Management also believes that the use of an adjusted effective tax rate provides improved insight into the tax effects of our ongoing business operations.
Additionally, the Management Development and Compensation Committee of the company's Board of Directors has used certain of the non-GAAP financial measures when setting and assessing achievement of incentive compensation goals. These goals are based, in part, on the company's adjusted earnings per share and improvement in the company's adjusted return on invested capital and adjusted operating profit return on sales determined by excluding certain of the charges that are used in calculating these non-GAAP financial measures.
Conference Call
A conference call to discuss this news release and other matters of interest to investors and analysts will be held at 9 a.m. (CST) today. The conference call will be simultaneously broadcast over the World Wide Web. Stockholders and others are invited to listen to the live broadcast or a playback, which can be accessed by following the instructions set out in the Investors section of the company's Web site (www.kimberly-clark.com).
About Kimberly-Clark
Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 175 countries. Every day, nearly a quarter of the world's population trust K-C brands and the solutions they provide to enhance their health, hygiene and well-being. With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds No. 1 or No. 2 share positions in 80 countries. To keep up with the latest K-C news and to learn more about the company's 144-year history of innovation, visit www.kimberly-clark.com.
Copies of Kimberly-Clark's Annual Report to Stockholders and its proxy statements and other SEC filings, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, are made available free of charge on the company's Web site on the same day they are filed with the SEC. To view these filings, visit the Investors section of the company's Web site.
Certain matters contained in this news release concerning the outlook, anticipated financial and operating results, raw material, energy and other input costs, anticipated currency rates and exchange risks, net income from equity companies, sources and uses of cash, the effective tax rate, the anticipated costs, scope, timing and financial and other effects of the 2014 Organization Restructuring, the anticipated cost savings from the company's FORCE program, growth initiatives, contingencies and anticipated transactions of the company constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company. There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. For a description of certain factors, such as currency rates and exchange risks, cost savings and reductions, raw material, energy and other input costs, competition, market demand and economic and political conditions, that could cause the company's future results to differ from those expressed in any such forward-looking statements, see Item 1A of the company's Annual Report on Form 10-K for the year ended December 31, 2014 entitled "Risk Factors."
KIMBERLY-CLARK CORPORATION |
||||||||||
CONSOLIDATED INCOME STATEMENT |
||||||||||
(Millions, except per share amounts) |
||||||||||
Three Months Ended December 31 |
||||||||||
2015 |
2014 |
Change |
||||||||
Net Sales |
$ |
4,539 |
$ |
4,828 |
-6.0 |
% |
||||
Cost of products sold |
2,913 |
3,275 |
-11.1 |
% |
||||||
Gross Profit |
1,626 |
1,553 |
+4.7 |
% |
||||||
Marketing, research and general expenses |
857 |
971 |
-11.7 |
% |
||||||
Other (income) and expense, net |
139 |
424 |
-67.2 |
% |
||||||
Operating Profit |
630 |
158 |
+298.7 |
% |
||||||
Interest income |
5 |
5 |
— |
|||||||
Interest expense |
(76) |
(69) |
+10.1 |
% |
||||||
Income From Continuing Operations Before Income Taxes and Equity Interests |
559 |
94 |
+494.7 |
% |
||||||
Provision for income taxes |
(252) |
(175) |
+44.0 |
% |
||||||
Income (Loss) From Continuing Operations Before Equity Interests |
307 |
(81) |
N.M. |
|||||||
Share of net income of equity companies |
37 |
33 |
+12.1 |
% |
||||||
Income (Loss) From Continuing Operations |
344 |
(48) |
N.M. |
|||||||
Income (loss) from discontinued operations, net of income taxes |
— |
(15) |
N.M. |
|||||||
Net Income (Loss) |
344 |
(63) |
N.M. |
|||||||
Net income attributable to noncontrolling interests in continuing operations |
(11) |
(20) |
-45.0 |
% |
||||||
Net Income (Loss) Attributable to Kimberly-Clark Corporation |
$ |
333 |
$ |
(83) |
N.M. |
|||||
Per Share Basis |
||||||||||
Net Income (Loss) Attributable to Kimberly-Clark Corporation |
||||||||||
Basic |
||||||||||
Continuing operations |
$ |
0.92 |
$ |
(0.18) |
N.M. |
|||||
Discontinued operations |
— |
(0.04) |
N.M. |
|||||||
Net income (loss) |
$ |
0.92 |
$ |
(0.22) |
N.M. |
|||||
Diluted |
||||||||||
Continuing operations |
$ |
0.91 |
$ |
(0.18) |
N.M. |
|||||
Discontinued operations |
— |
(0.04) |
N.M. |
|||||||
Net income (loss) |
$ |
0.91 |
$ |
(0.22) |
N.M. |
|||||
Cash Dividends Declared |
$ |
0.88 |
$ |
0.84 |
+4.8 |
% |
||||
Common Shares Outstanding |
December 31 |
|||||||||
2015 |
2014 |
|||||||||
Outstanding shares as of |
360.9 |
365.3 |
||||||||
Average diluted shares for three months ended |
364.5 |
373.0 |
||||||||
N.M. – Not Meaningful |
Unaudited |
KIMBERLY-CLARK CORPORATION |
||||||||||
CONSOLIDATED INCOME STATEMENT |
||||||||||
(Millions, except per share amounts) |
||||||||||
Twelve Months Ended December 31 |
||||||||||
2015 |
2014 |
Change |
||||||||
Net Sales |
$ |
18,591 |
$ |
19,724 |
-5.7 |
% |
||||
Cost of products sold |
11,967 |
13,041 |
-8.2 |
% |
||||||
Gross Profit |
6,624 |
6,683 |
-0.9 |
% |
||||||
Marketing, research and general expenses |
3,443 |
3,709 |
-7.2 |
% |
||||||
Other (income) and expense, net |
1,568 |
453 |
+246.1 |
% |
||||||
Operating Profit |
1,613 |
2,521 |
-36.0 |
% |
||||||
Interest income |
17 |
18 |
-5.6 |
% |
||||||
Interest expense |
(295) |
(284) |
+3.9 |
% |
||||||
Income From Continuing Operations Before Income Taxes and Equity Interests |
1,335 |
2,255 |
-40.8 |
% |
||||||
Provision for income taxes |
(418) |
(856) |
-51.2 |
% |
||||||
Income From Continuing Operations Before Equity Interests |
917 |
1,399 |
-34.5 |
% |
||||||
Share of net income of equity companies |
149 |
146 |
+2.1 |
% |
||||||
Income From Continuing Operations |
1,066 |
1,545 |
-31.0 |
% |
||||||
Income from discontinued operations, net of income taxes |
— |
50 |
N.M. |
|||||||
Net Income |
1,066 |
1,595 |
-33.2 |
% |
||||||
Net income attributable to noncontrolling interests in continuing operations |
(53) |
(69) |
-23.2 |
% |
||||||
Net Income Attributable to Kimberly-Clark Corporation |
$ |
1,013 |
$ |
1,526 |
-33.6 |
% |
||||
Per Share Basis |
||||||||||
Net Income Attributable to Kimberly-Clark Corporation |
||||||||||
Basic |
||||||||||
Continuing operations |
$ |
2.78 |
$ |
3.94 |
-29.4 |
% |
||||
Discontinued operations |
— |
0.13 |
N.M. |
|||||||
Net income |
$ |
2.78 |
$ |
4.07 |
-31.7 |
% |
||||
Diluted |
||||||||||
Continuing operations |
$ |
2.77 |
$ |
3.91 |
-29.2 |
% |
||||
Discontinued operations |
— |
0.13 |
N.M. |
|||||||
Net income |
$ |
2.77 |
$ |
4.04 |
-31.4 |
% |
||||
Cash Dividends Declared |
$ |
3.52 |
$ |
3.36 |
+4.8 |
% |
||||
Common Shares Outstanding |
December 31 |
|||||||||
2015 |
2014 |
|||||||||
Average diluted shares for twelve months ended |
366.3 |
377.4 |
||||||||
N.M. – Not Meaningful |
2015 Data is Unaudited |
KIMBERLY-CLARK CORPORATION |
|||||||||||||||||||||||||||||
NON-GAAP RECONCILIATIONS |
|||||||||||||||||||||||||||||
(Millions, except per share amounts) |
|||||||||||||||||||||||||||||
Three Months Ended December 31, 2015 |
|||||||||||||||||||||||||||||
As Reported |
Charges Related to Venezuelan Operations |
Uncertain Tax Positions Adjustment |
Charges for Pension Settlements |
Charges for 2014 Organization Restructuring |
Charges for Turkey Restructuring |
As Adjusted Non-GAAP |
|||||||||||||||||||||||
Cost of products sold |
$ |
2,913 |
$ |
— |
$ |
— |
$ |
— |
$ |
4 |
$ |
6 |
$ |
2,903 |
|||||||||||||||
Gross profit |
1,626 |
— |
— |
— |
(4) |
(6) |
1,636 |
||||||||||||||||||||||
Marketing, research and general expenses |
857 |
— |
— |
— |
23 |
— |
834 |
||||||||||||||||||||||
Other (income) and expense, net |
139 |
108 |
— |
8 |
— |
— |
23 |
||||||||||||||||||||||
Operating profit |
630 |
(108) |
— |
(8) |
(27) |
(6) |
779 |
||||||||||||||||||||||
Income from continuing operations before income taxes and equity interests |
559 |
(108) |
— |
(8) |
(27) |
(6) |
708 |
||||||||||||||||||||||
Provision for income taxes |
(252) |
6 |
(49) |
3 |
5 |
— |
(217) |
||||||||||||||||||||||
Effective tax rate |
45.1 |
% |
— |
— |
— |
— |
— |
30.6 |
% |
||||||||||||||||||||
Net income attributable to Kimberly-Clark Corporation |
333 |
(102) |
(49) |
(5) |
(22) |
(6) |
517 |
||||||||||||||||||||||
Diluted earnings per share(a) |
0.91 |
(0.28) |
(0.13) |
(0.01) |
(0.06) |
(0.02) |
1.42 |
||||||||||||||||||||||
(a) |
"As Adjusted Non-GAAP" does not equal "As Reported" plus "Charges" as a result of rounding. |
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. The company compensates for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures. |
Unaudited |
KIMBERLY-CLARK CORPORATION |
||||||||||||||||||||||||||||
NON-GAAP RECONCILIATIONS |
||||||||||||||||||||||||||||
(Millions, except per share amounts) |
||||||||||||||||||||||||||||
Three Months Ended December 31, 2014 |
||||||||||||||||||||||||||||
As Reported |
Charges for European Strategic Changes |
Charges Related to Health Care Spin-off |
Regulatory Dispute in Middle East |
Charges for 2014 Organization Restructuring |
Charges Related to Venezuelan Operations |
As Adjusted Non-GAAP |
||||||||||||||||||||||
Cost of products sold |
$ |
3,275 |
$ |
2 |
$ |
— |
$ |
— |
$ |
40 |
$ |
41 |
$ |
3,192 |
||||||||||||||
Gross profit |
1,553 |
(2) |
— |
— |
(40) |
(41) |
1,636 |
|||||||||||||||||||||
Marketing, research and general expenses |
971 |
18 |
— |
— |
93 |
— |
860 |
|||||||||||||||||||||
Other (income) and expense, net |
424 |
— |
— |
(4) |
— |
421 |
7 |
|||||||||||||||||||||
Operating profit |
158 |
(20) |
— |
4 |
(133) |
(462) |
769 |
|||||||||||||||||||||
Income from continuing operations before income taxes and equity interests |
94 |
(20) |
— |
4 |
(133) |
(462) |
705 |
|||||||||||||||||||||
Provision for income taxes |
(175) |
2 |
— |
— |
38 |
— |
(215) |
|||||||||||||||||||||
Effective tax rate |
186.2 |
% |
— |
— |
— |
— |
— |
30.5 |
% |
|||||||||||||||||||
Income (loss) from continuing operations |
(48) |
(18) |
— |
4 |
(95) |
(462) |
523 |
|||||||||||||||||||||
Net income attributable to noncontrolling interests in continuing operations |
(20) |
— |
— |
(2) |
— |
— |
(18) |
|||||||||||||||||||||
Income (loss) from continuing operations attributable to Kimberly-Clark Corporation |
(68) |
(18) |
— |
2 |
(95) |
(462) |
505 |
|||||||||||||||||||||
Diluted earnings (loss) per share from continuing operations |
(0.18) |
(0.05) |
— |
0.01 |
(0.25) |
(1.24) |
1.35 |
|||||||||||||||||||||
Income (loss) from discontinued operations, net of income taxes |
(15) |
— |
(44) |
— |
— |
— |
29 |
|||||||||||||||||||||
Diluted earnings (loss) per share from discontinued operations |
(0.04) |
— |
(0.12) |
— |
— |
— |
0.08 |
|||||||||||||||||||||
Net income (loss) attributable to Kimberly-Clark Corporation |
(83) |
(18) |
(44) |
2 |
(95) |
(462) |
534 |
|||||||||||||||||||||
Diluted earnings (loss) per share |
(0.22) |
(0.05) |
(0.12) |
0.01 |
(0.25) |
(1.24) |
1.43 |
Unaudited |
KIMBERLY-CLARK CORPORATION |
|||||||||||||||||||||||||||||
NON-GAAP RECONCILIATIONS |
|||||||||||||||||||||||||||||
(Millions, except per share amounts) |
|||||||||||||||||||||||||||||
Twelve Months Ended December 31, 2015 |
|||||||||||||||||||||||||||||
As Reported |
Charges Related to Venezuelan Operations |
Uncertain Tax Positions Adjustment |
Charges for Pension Settlements |
Charges for 2014 Organization Restructuring |
Charges for Turkey Restructuring |
As Adjusted Non-GAAP |
|||||||||||||||||||||||
Cost of products sold |
$ |
11,967 |
$ |
5 |
$ |
— |
$ |
— |
$ |
23 |
$ |
22 |
$ |
11,917 |
|||||||||||||||
Gross profit |
6,624 |
(5) |
— |
— |
(23) |
(22) |
6,674 |
||||||||||||||||||||||
Marketing, research and general expenses |
3,443 |
— |
— |
— |
40 |
1 |
3,402 |
||||||||||||||||||||||
Other (income) and expense, net |
1,568 |
148 |
— |
1,358 |
— |
— |
62 |
||||||||||||||||||||||
Operating profit |
1,613 |
(153) |
— |
(1,358) |
(63) |
(23) |
3,210 |
||||||||||||||||||||||
Income from continuing operations before income taxes and equity interests |
1,335 |
(153) |
— |
(1,358) |
(63) |
(23) |
2,932 |
||||||||||||||||||||||
Provision for income taxes |
(418) |
6 |
(49) |
523 |
21 |
— |
(919) |
||||||||||||||||||||||
Effective tax rate |
31.3 |
% |
— |
— |
— |
— |
— |
31.3 |
% |
||||||||||||||||||||
Net income attributable to Kimberly-Clark Corporation |
1,013 |
(147) |
(49) |
(835) |
(42) |
(23) |
2,109 |
||||||||||||||||||||||
Diluted earnings per share(a) |
2.77 |
(0.40) |
(0.13) |
(2.28) |
(0.11) |
(0.06) |
5.76 |
||||||||||||||||||||||
(a) |
"As Adjusted Non-GAAP" does not equal "As Reported" plus "Charges" as a result of rounding. |
Unaudited |
KIMBERLY-CLARK CORPORATION |
||||||||||||||||||||||||||||
NON-GAAP RECONCILIATIONS |
||||||||||||||||||||||||||||
(Millions, except per share amounts) |
||||||||||||||||||||||||||||
Twelve Months Ended December 31, 2014 |
||||||||||||||||||||||||||||
As Reported |
Charges for European Strategic Changes |
Charges Related to Health Care Spin-off |
Charge Related to Regulatory Dispute in Middle East |
Charges for 2014 Organization Restructuring |
Charges Related to Venezuelan Operations |
As Adjusted Non-GAAP |
||||||||||||||||||||||
Cost of products sold |
$ |
13,041 |
$ |
11 |
$ |
— |
$ |
— |
$ |
40 |
$ |
41 |
$ |
12,949 |
||||||||||||||
Gross profit |
6,683 |
(11) |
— |
— |
(40) |
(41) |
6,775 |
|||||||||||||||||||||
Marketing, research and general expenses |
3,709 |
22 |
— |
— |
93 |
— |
3,594 |
|||||||||||||||||||||
Other (income) and expense, net |
453 |
— |
— |
35 |
— |
421 |
(3) |
|||||||||||||||||||||
Operating profit |
2,521 |
(33) |
— |
(35) |
(133) |
(462) |
3,184 |
|||||||||||||||||||||
Income from continuing operations before income taxes and equity interests |
2,255 |
(33) |
— |
(35) |
(133) |
(462) |
2,918 |
|||||||||||||||||||||
Provision for income taxes |
(856) |
3 |
— |
— |
38 |
— |
(897) |
|||||||||||||||||||||
Effective tax rate |
38.0 |
% |
— |
— |
— |
— |
— |
30.7 |
% |
|||||||||||||||||||
Income from continuing operations |
1,545 |
(30) |
— |
(35) |
(95) |
(462) |
2,167 |
|||||||||||||||||||||
Net income attributable to noncontrolling interests in continuing operations |
(69) |
— |
— |
18 |
— |
— |
(87) |
|||||||||||||||||||||
Income from continuing operations attributable to Kimberly-Clark Corporation |
1,476 |
(30) |
— |
(17) |
(95) |
(462) |
2,080 |
|||||||||||||||||||||
Diluted earnings per share from continuing operations |
3.91 |
(0.08) |
— |
(0.05) |
(0.25) |
(1.22) |
5.51 |
|||||||||||||||||||||
Income from discontinued operations, net of income taxes |
50 |
— |
(138) |
— |
— |
— |
188 |
|||||||||||||||||||||
Diluted earnings per share from discontinued operations |
0.13 |
— |
(0.37) |
— |
— |
— |
0.50 |
|||||||||||||||||||||
Net income attributable to Kimberly-Clark Corporation |
1,526 |
(30) |
(138) |
(17) |
(95) |
(462) |
2,268 |
|||||||||||||||||||||
Diluted earnings per share |
4.04 |
(0.08) |
(0.37) |
(0.05) |
(0.25) |
(1.22) |
6.01 |
Unaudited |
KIMBERLY-CLARK CORPORATION |
|||||||
CONSOLIDATED BALANCE SHEET |
|||||||
(Millions) |
|||||||
December 31 |
|||||||
2015 |
2014 |
||||||
ASSETS |
|||||||
Current Assets |
|||||||
Cash and cash equivalents |
$ |
619 |
$ |
789 |
|||
Accounts receivable, net |
2,281 |
2,223 |
|||||
Inventories |
1,909 |
1,892 |
|||||
Other current assets |
617 |
655 |
|||||
Total Current Assets |
5,426 |
5,559 |
|||||
Property, Plant and Equipment, Net |
7,104 |
7,359 |
|||||
Investments in Equity Companies |
247 |
257 |
|||||
Goodwill |
1,446 |
1,628 |
|||||
Other Assets |
619 |
723 |
|||||
TOTAL ASSETS |
$ |
14,842 |
$ |
15,526 |
|||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||
Current Liabilities |
|||||||
Debt payable within one year |
$ |
1,669 |
$ |
1,326 |
|||
Trade accounts payable |
2,612 |
2,616 |
|||||
Accrued expenses |
1,750 |
1,974 |
|||||
Dividends payable |
318 |
310 |
|||||
Total Current Liabilities |
6,349 |
6,226 |
|||||
Long-Term Debt |
6,106 |
5,630 |
|||||
Noncurrent Employee Benefits |
1,137 |
1,693 |
|||||
Deferred Income Taxes |
766 |
587 |
|||||
Other Liabilities |
380 |
319 |
|||||
Redeemable Preferred Securities of Subsidiaries |
64 |
72 |
|||||
Stockholders' Equity (Deficit) |
|||||||
Kimberly-Clark Corporation |
(174) |
729 |
|||||
Noncontrolling Interests |
214 |
270 |
|||||
Total Stockholders' Equity |
40 |
999 |
|||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
$ |
14,842 |
$ |
15,526 |
2015 Data is Unaudited |
KIMBERLY-CLARK CORPORATION |
|||||||||||||||
CONSOLIDATED CASH FLOW STATEMENT |
|||||||||||||||
(Millions) |
|||||||||||||||
Three Months Ended December 31 |
Twelve Months Ended December 31 |
||||||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||||||
Operating Activities |
|||||||||||||||
Net income (loss) |
$ |
344 |
$ |
(63) |
$ |
1,066 |
$ |
1,595 |
|||||||
Depreciation and amortization |
181 |
207 |
746 |
862 |
|||||||||||
Asset impairments |
2 |
— |
22 |
42 |
|||||||||||
Stock-based compensation |
7 |
1 |
75 |
52 |
|||||||||||
Deferred income taxes |
123 |
6 |
(255) |
63 |
|||||||||||
Net (gains) losses on asset dispositions |
12 |
32 |
17 |
21 |
|||||||||||
Equity companies' earnings (in excess of) less than dividends paid |
28 |
55 |
(10) |
28 |
|||||||||||
(Increase) decrease in operating working capital |
(129) |
(113) |
(445) |
(176) |
|||||||||||
Postretirement benefits |
(11) |
17 |
930 |
(102) |
|||||||||||
Charges related to Venezuelan Operations |
108 |
462 |
153 |
462 |
|||||||||||
Other |
— |
(14) |
7 |
(2) |
|||||||||||
Cash Provided by Operations |
665 |
590 |
2,306 |
2,845 |
|||||||||||
Investing Activities |
|||||||||||||||
Capital spending |
(258) |
(309) |
(1,056) |
(1,039) |
|||||||||||
Proceeds from dispositions of property |
1 |
2 |
27 |
38 |
|||||||||||
Proceeds from sales of investments |
— |
31 |
— |
127 |
|||||||||||
Investments in time deposits |
(46) |
(28) |
(146) |
(151) |
|||||||||||
Maturities of time deposits |
64 |
48 |
164 |
239 |
|||||||||||
Other |
12 |
11 |
(39) |
16 |
|||||||||||
Cash Used for Investing |
(227) |
(245) |
(1,050) |
(770) |
|||||||||||
Financing Activities |
|||||||||||||||
Cash dividends paid |
(320) |
(314) |
(1,272) |
(1,256) |
|||||||||||
Change in short-term debt |
412 |
568 |
303 |
721 |
|||||||||||
Debt proceeds |
3 |
636 |
1,100 |
1,257 |
|||||||||||
Debt repayments |
(204) |
(14) |
(553) |
(123) |
|||||||||||
Redemption of redeemable preferred securities of subsidiary |
— |
(500) |
— |
(500) |
|||||||||||
Cash paid on redeemable preferred securities of subsidiaries |
(2) |
(12) |
(3) |
(34) |
|||||||||||
Proceeds from exercise of stock options |
38 |
29 |
140 |
127 |
|||||||||||
Acquisitions of common stock for the treasury |
(358) |
(817) |
(861) |
(1,939) |
|||||||||||
Cash transferred to Halyard Health, Inc. related to spin-off |
— |
(120) |
— |
(120) |
|||||||||||
Shares purchased from noncontrolling interest |
— |
— |
(151) |
— |
|||||||||||
Other |
(8) |
(26) |
(1) |
(26) |
|||||||||||
Cash Used for Financing |
(439) |
(570) |
(1,298) |
(1,893) |
|||||||||||
Effect of Exchange Rate Changes on Cash and Cash Equivalents |
(23) |
(417) |
(128) |
(447) |
|||||||||||
Increase (Decrease) in Cash and Cash Equivalents |
(24) |
(642) |
(170) |
(265) |
|||||||||||
Cash and Cash Equivalents - Beginning of Period |
643 |
1,431 |
789 |
1,054 |
|||||||||||
Cash and Cash Equivalents - End of Period |
$ |
619 |
$ |
789 |
$ |
619 |
$ |
789 |
Unaudited |
KIMBERLY-CLARK CORPORATION |
||||||||||||||||||||||
SELECTED BUSINESS SEGMENT DATA |
||||||||||||||||||||||
(Millions) |
||||||||||||||||||||||
Three Months Ended December 31 |
Twelve Months Ended December 31 |
|||||||||||||||||||||
2015 |
2014 |
Change |
2015 |
2014 |
Change |
|||||||||||||||||
NET SALES |
||||||||||||||||||||||
Personal Care |
$ |
2,233 |
$ |
2,336 |
-4.4 |
% |
$ |
9,204 |
$ |
9,635 |
-4.5 |
% |
||||||||||
Consumer Tissue |
1,520 |
1,621 |
-6.2 |
% |
6,121 |
6,645 |
-7.9 |
% |
||||||||||||||
K-C Professional |
776 |
857 |
-9.5 |
% |
3,219 |
3,388 |
-5.0 |
% |
||||||||||||||
Corporate & Other |
10 |
14 |
N.M. |
47 |
56 |
N.M. |
||||||||||||||||
TOTAL NET SALES |
$ |
4,539 |
$ |
4,828 |
-6.0 |
% |
$ |
18,591 |
$ |
19,724 |
-5.7 |
% |
||||||||||
OPERATING PROFIT |
||||||||||||||||||||||
Personal Care |
$ |
473 |
$ |
410 |
+15.4 |
% |
$ |
1,885 |
$ |
1,803 |
+4.5 |
% |
||||||||||
Consumer Tissue |
262 |
280 |
-6.4 |
% |
1,073 |
1,062 |
+1.0 |
% |
||||||||||||||
K-C Professional |
157 |
151 |
+4.0 |
% |
590 |
604 |
-2.3 |
% |
||||||||||||||
Corporate & Other(a) |
(123) |
(259) |
N.M. |
(367) |
(495) |
N.M. |
||||||||||||||||
Other (income) and expense, |
139 |
424 |
-67.2 |
% |
1,568 |
453 |
+246.1 |
% |
||||||||||||||
TOTAL OPERATING PROFIT |
$ |
630 |
$ |
158 |
+298.7 |
% |
$ |
1,613 |
$ |
2,521 |
-36.0 |
% |
(a) |
Segment Operating Profit excludes other (income) and expense, net and expenses not associated with the business segments, including charges as indicated in the Non-GAAP Reconciliations. |
N.M. – Not Meaningful |
Unaudited |
KIMBERLY-CLARK CORPORATION |
|||||||||||||||
SELECTED BUSINESS SEGMENT DATA |
|||||||||||||||
PERCENTAGE CHANGE IN NET SALES VERSUS PRIOR YEAR |
|||||||||||||||
Three Months Ended December 31, 2015 |
|||||||||||||||
Total |
Volume |
Net Price |
Mix/ Other(a) |
Currency |
|||||||||||
Personal Care |
(4.4) |
6 |
1 |
1 |
(12) |
||||||||||
Consumer Tissue |
(6.2) |
4 |
(1) |
— |
(9) |
||||||||||
K-C Professional |
(9.5) |
(2) |
2 |
— |
(9) |
||||||||||
TOTAL CONSOLIDATED |
(6.0) |
4 |
1 |
— |
(11) |
Twelve Months Ended December 31, 2015 |
||||||||||||||
Total |
Volume |
Net Price |
Mix/ Other(a) |
Currency |
||||||||||
Personal Care |
(4.5) |
5 |
1 |
1 |
(11) |
|||||||||
Consumer Tissue |
(7.9) |
3 |
(1) |
(1) |
(9) |
|||||||||
K-C Professional |
(5.0) |
2 |
— |
2 |
(9) |
|||||||||
TOTAL CONSOLIDATED |
(5.7) |
4 |
— |
— |
(10) |
(a) |
Mix/Other includes rounding. |
Unaudited |
KIMBERLY-CLARK CORPORATION |
||||||||||
OUTLOOK FOR 2016 |
||||||||||
Estimated Range |
||||||||||
ESTIMATED FULL YEAR 2016 DILUTED EARNINGS PER SHARE |
||||||||||
Adjusted earnings per share |
$ |
5.95 |
- |
$ |
6.15 |
|||||
Adjustment for charges related to the 2014 Organization Restructuring |
(0.06) |
- |
(0.03) |
|||||||
Per share basis – diluted net income attributable to Kimberly-Clark Corporation |
$ |
5.89 |
- |
$ |
6.12 |
|||||
[KMB-F]
Logo - http://photos.prnewswire.com/prnh/20110928/DA76879LOGO
SOURCE Kimberly-Clark Corporation
Share this article